Compounded Semaglutide Storage & Shelf Life Guide

Last reviewed: May 30, 2026

Last updated: May 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Compounded semaglutide typically remains stable for 28 to 36 days when refrigerated at 2–8°C (36–46°F), though stability windows vary based on compounding pharmacy protocols and formulation specifics. Improper storage—including temperature fluctuations, light exposure, or extended room-temperature exposure—can degrade the active ingredient and compromise clinical outcomes.

Patients using compounded semaglutide must understand that storage stability directly correlates with treatment effectiveness. Unlike branded options, each compounded formulation carries specific storage instructions from the preparing 503A pharmacy. PlexusDx prioritizes education on these requirements because medication integrity is foundational to achieving meaningful metabolic and weight-management results.

Temperature Control as the Primary Stability Factor

Compounded semaglutide solutions are temperature-sensitive biologics. The 2–8°C refrigeration window (standard for most 503A preparations) prevents bacterial growth and maintains molecular structure. Even brief exposure to room temperature or freezing can initiate degradation cascades that reduce potency without visible signs of decomposition.

Once removed from refrigeration for a dose, vials should return to cold storage within 30 minutes. Some compounding protocols allow limited room-temperature stability (up to 8 hours for certain formulations), but extended storage outside refrigeration creates unpredictable potency loss. Your compounding pharmacy's specific guidance takes precedence over general recommendations.

Compounded Semaglutide Stability Variables: A Clinical Comparison Framework

Shelf life and potency retention depend on multiple factors beyond temperature alone. Compounding concentration, vial material, preservative selection, and even transport conditions influence how long a preparation remains therapeutically viable. Below is a framework for evaluating stability across common scenarios.

Storage Condition	Expected Stability Window	Potency Risk Level	Recommended Action
Refrigerated 2–8°C (36–46°F), sealed	28–36 days from dispensing	Low	Standard storage; use within pharmacy timeline
Unrefrigerated 15–25°C (59–77°F) for <8 hours	Up to 8 hours (formulation-dependent)	Moderate	Acceptable for travel; return to refrigeration immediately
Frozen at <0°C (32°F) or repeated freeze-thaw	Immediate degradation likely	High	Do not use; contact pharmacy for replacement
Light-exposed (direct sunlight or UV)	Rapid degradation within hours	High	Store in opaque container; discard if visibly discolored

Practical Storage Protocols for Home Use and Travel

At home, dedicate a dedicated refrigerator shelf (not the door, where temperature fluctuates) for compounded semaglutide. Keep vials in their original packaging or an opaque storage container to minimize light exposure. Record the dispensing date on each vial and establish a simple rotation system to use older vials first.

During travel, use a portable cooler or insulated medication travel case with temperature-monitoring stickers. Many patients transport vials with ice packs or reusable gel packs; ensure packs do not freeze the vials directly. If traveling internationally, confirm customs regulations for injectable medications and carry a pharmacy label or provider letter documenting medical necessity.

Recognizing Degradation and Communicating with Your Provider

Visual inspection offers limited detection of degradation; semaglutide solutions may appear clear and colorless even after potency loss. Signs of concern include crystallization, cloudiness, discoloration, or particles floating in the vial. If any visual abnormality is observed, do not use the medication and contact your compounding pharmacy immediately.

Before starting compounded semaglutide, establish a baseline conversation with your healthcare provider about storage, handling, and what to do if you suspect potency compromise. Some patients benefit from biomarker assessment (fasting glucose, lipid panel, metabolic markers) before and during treatment to objectively evaluate whether therapy is meeting expected clinical milestones. If clinical response plateaus unexpectedly, storage integrity or formulation stability may be contributing factors worth discussing.

How PlexusDx Supports a More Personalized Approach

PlexusDx partners with licensed 503A compounding pharmacies that provide detailed storage and stability documentation with each prescription. This transparency allows patients to understand exactly how long their specific formulation remains potent and what conditions preserve it. Your compounding pharmacy's stability data—tailored to the exact preparation you receive—should guide all storage decisions; PlexusDx recommends keeping this information accessible for reference.

The Precision Peptide Genetic Test may help provide context regarding your individual GLP-1 receptor sensitivity and metabolic predispositions. While genetic variants (such as GLP1R rs6923761) do not predict exact medication response, they can help your provider interpret whether suboptimal clinical results stem from genetic factors, dosing, or potential storage/formulation issues. This contextual understanding should be interpreted with a qualified healthcare provider alongside objective clinical assessment.

Integrating storage integrity into your broader treatment plan supports more informed provider conversations. If you experience unexpected plateaus or inconsistent results on compounded semaglutide, discussing storage compliance, baseline biomarkers, and individual metabolic factors (informed by genetic insights if available) can help your provider optimize your approach. Proper storage is a modifiable variable that directly supports treatment efficacy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $229-$309/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.